GoodRx Holdings, Inc. Research and Development Expense
GoodRx Holdings, Inc. (GDRX) reported Research and Development Expense of $26.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05
- GoodRx Holdings, Inc. research and development expense for the quarter ending 2026-06-30 was $26.71M, a 10.76% decline year-over-year.
- GoodRx Holdings, Inc. research and development expense for the quarter ending 2026-03-31 was $30.18M, a 3.10% decline year-over-year.
- GoodRx Holdings, Inc. research and development expense for the quarter ending 2025-12-31 was $28.94M, a 8.82% decline year-over-year.
- GoodRx Holdings, Inc. research and development expense for the quarter ending 2025-09-30 was $31.01M, a 2.90% increase year-over-year.
- GoodRx Holdings, Inc. research and development expense for fiscal 2025 was $121.03M, a 2.20% decline from fiscal 2024.
- GoodRx Holdings, Inc. research and development expense for fiscal 2024 was $123.75M, a 8.90% decline from fiscal 2023.
- GoodRx Holdings, Inc. research and development expense for fiscal 2023 was $135.84M, a 5.10% decline from fiscal 2022.
- GoodRx Holdings, Inc. research and development expense for fiscal 2022 was $143.14M, a 13.73% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $26.71M 10-Q · filed 2026-08-05 | $56.89M 10-Q · filed 2026-08-05 | $85.83M derived: sum of 3 quarters · filed 2026-08-05 | $116.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $30.18M 10-Q · filed 2026-05-06 | $59.12M derived: sum of 2 quarters · filed 2026-05-06 | $90.13M derived: sum of 3 quarters · filed 2026-05-06 | $120.06M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $28.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $59.95M derived: sum of 2 quarters · filed 2026-02-26 | $89.88M derived: sum of 3 quarters · filed 2026-08-05 | $121.03M 10-K · filed 2026-02-26 |
| 2025-09-30 | $31.01M 10-Q · filed 2025-11-04 | $60.95M derived: sum of 2 quarters · filed 2026-08-05 | $92.09M 10-Q · filed 2025-11-04 | $123.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $29.93M 10-Q · filed 2026-08-05 | $61.08M 10-Q · filed 2026-08-05 | $92.81M derived: sum of 3 quarters · filed 2026-08-05 | $122.95M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $31.14M 10-Q · filed 2026-05-06 | $62.88M derived: sum of 2 quarters · filed 2026-05-06 | $93.02M derived: sum of 3 quarters · filed 2026-05-06 | $123.87M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $31.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $61.88M derived: sum of 2 quarters · filed 2026-02-26 | $92.73M derived: sum of 3 quarters · filed 2026-02-26 | $123.75M 10-K · filed 2026-02-26 |
| 2024-09-30 | $30.14M 10-Q · filed 2025-11-04 | $60.99M derived: sum of 2 quarters · filed 2025-11-04 | $92.01M 10-Q · filed 2025-11-04 | $124.04M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $30.85M 10-Q · filed 2025-08-06 | $61.87M 10-Q · filed 2025-08-06 | $93.90M derived: sum of 3 quarters · filed 2026-02-26 | $133.51M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $31.02M 10-Q · filed 2025-05-07 | $63.05M derived: sum of 2 quarters · filed 2026-02-26 | $102.66M derived: sum of 3 quarters · filed 2026-02-26 | $133.94M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $32.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $71.64M derived: sum of 2 quarters · filed 2026-02-26 | $102.93M derived: sum of 3 quarters · filed 2026-02-26 | $135.84M 10-K · filed 2026-02-26 |
| 2023-09-30 | $39.61M 10-Q · filed 2024-11-07 | $70.90M derived: sum of 2 quarters · filed 2024-11-07 | $103.80M 10-Q · filed 2024-11-07 | $140.57M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $31.29M 10-Q · filed 2024-08-08 | $64.19M 10-Q · filed 2024-08-08 | $100.96M derived: sum of 3 quarters · filed 2025-02-27 | $136.88M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $32.91M 10-Q · filed 2024-05-09 | $69.68M derived: sum of 2 quarters · filed 2025-02-27 | $105.60M derived: sum of 3 quarters · filed 2025-02-27 | $141.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $36.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $72.69M derived: sum of 2 quarters · filed 2025-02-27 | $108.09M derived: sum of 3 quarters · filed 2025-02-27 | $143.14M 10-K · filed 2025-02-27 |
| 2022-09-30 | $35.92M 10-Q · filed 2023-11-09 | $71.33M derived: sum of 2 quarters · filed 2023-11-09 | $106.37M 10-Q · filed 2023-11-09 | $141.43M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $35.40M 10-Q · filed 2023-08-09 | $70.45M 10-Q · filed 2023-08-09 | $105.51M derived: sum of 3 quarters · filed 2024-02-29 | $140.58M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $35.04M 10-Q · filed 2023-05-10 | $70.10M derived: sum of 2 quarters · filed 2024-02-29 | $105.17M derived: sum of 3 quarters · filed 2024-02-29 | $134.74M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $35.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $70.13M derived: sum of 2 quarters · filed 2024-02-29 | $99.70M derived: sum of 3 quarters · filed 2024-02-29 | $125.86M 10-K · filed 2024-02-29 |
| 2021-09-30 | $35.07M 10-Q · filed 2022-11-09 | $64.64M derived: sum of 2 quarters · filed 2022-11-09 | $90.80M 10-Q · filed 2022-11-09 | $114.48M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $29.57M 10-Q · filed 2022-08-09 | $55.73M 10-Q · filed 2022-08-09 | $79.41M derived: sum of 3 quarters · filed 2023-03-01 | $95.26M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $26.16M 10-Q · filed 2022-05-10 | $49.84M derived: sum of 2 quarters · filed 2023-03-01 | $65.69M derived: sum of 3 quarters · filed 2023-03-01 | $77.65M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $23.68M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $39.53M derived: sum of 2 quarters · filed 2023-03-01 | $51.49M derived: sum of 3 quarters · filed 2023-03-01 | $61.82M 10-K · filed 2023-03-01 |
| 2020-09-30 | $15.85M 10-Q · filed 2021-11-12 | $27.81M derived: sum of 2 quarters · filed 2021-11-12 | $38.13M 10-Q · filed 2021-11-12 | $47.95M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $11.96M 10-Q · filed 2021-08-12 | $22.29M 10-Q · filed 2021-08-12 | $32.11M derived: sum of 3 quarters · filed 2022-03-01 | $39.95M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $10.32M 10-Q · filed 2021-05-14 | $20.14M derived: sum of 2 quarters · filed 2022-03-01 | $27.99M derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | $9.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $17.66M derived: sum of 2 quarters · filed 2022-03-01 | $29.30M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $7.84M 10-Q · filed 2020-11-12 | $19.48M 10-Q · filed 2020-11-12 | ||
| 2018-12-31 | $43.89M 10-K · filed 2021-03-12 |